PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 6, 2025Frontiers in Cellular and Infection Microbiology6 citationsOpen Access

Gut-to-tumor translocation of multidrug-resistant Klebsiella pneumoniae shapes the microbiome and chemoresistance in pancreatic cancer

View Full Paper
MGMuxi GeXZXinyang Zhao

Key Points

  • Significant alterations in gut microbiota observed in pancreatic cancer patients, indicating a unique microbial profile.
  • Increased microbial diversity in pancreatic cancer patients compared to healthy controls; specific species identified as x carriers of antibiotic resistance genes.
  • Analysis of tumor tissue and pancreatic fluid uncovered gut-derived multidrug-resistant Klebsiella pneumoniae in pancreatic cancer samples.
  • Co-occurrence patterns between antibiotic resistance genes and specific microbiota highlight potential mechanisms of chemoresistance.

Abstract

Background Despite advances and successes in precision oncology, pancreatic cancer (PC) remains a tumor with extremely low survival rates, and many of these cases experienced postoperative recurrence and metastasis. Alterations in the gut microbiota have been linked to the survival rates of PC patients. Nevertheless, the complexity of gut microbiota composition poses significant challenges in identifying definitive clinical biomarkers for PC. Methods Fecal samples were collected from PC patients, half of whom had metastasis, and their matched healthy controls (HCs). A metagenomic analysis was employed to further investigate the functional features of gut microbiota with both PC and metastatic PC. The clinical correlations, microbial metabolic pathways and antibiotic resistome were further assessed. In a follow-up validation, intraoperative tumor tissue and pancreatic fluid were sampled from PC patients and underwent comprehensive microbiological analysis, including bacterial culture, mass spectrometry-based identification, and third-generation whole-genome sequencing of Klebsiella pneumoniae isolates. Results We observed a significant alteration of the gut microbiota in PC patients, highlighted by an overall increase in microbial diversity compared to healthy controls ( p 0.05). Comparative abundance analysis identified 59 differentially abundant microbial species in non-metastatic pancreatic cancer (NMPC) (56 increased, 3 decreased) and 21 in metastatic pancreatic cancer (MPC) (19 increased, 2 decreased), alongside 18 significantly altered microbial metabolic pathways (FDR-adjusted p 0.05). Notably, Klebsiella pneumoniae , Klebsiella oxytoca , and Akkermansia muciniphila were identified as prominent antibiotic resistance gene (ARG) carriers in the gut microbiota of PC patients, with 653 ARG subtypes detected across fecal samples, 38–47% of which were shared among groups. Strong co-occurrence patterns between ARGs (e.g., acrB , mdtC , cpxA , emr , pmrF ) and the above species were observed predominantly in MPC samples ( p 0.05). Whole-genome sequencing of 14 isolates obtained from tumor tissue and pancreatic fluid revealed consistent ARG profiles and virulence genes, corroborating the metagenomic findings and supporting the hypothesis of gut-to-tumor translocation and potential intratumoral colonization. Conclusion This study provides a comprehensive microbiome-based insight into PC and its metastatic subtypes. By integrating microbiome analysis with microbial culture, this study provides direct evidence of gut-derived multidrug-resistant (MDR) K. pneumoniae colonization in PC tissues.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ge et al. (2025) studied this question.

synapsesocial.com/papers/69337cceb3f947a0a1259cc2https://doi.org/10.3389/fcimb.2025.1694479
Ask AI
Helpful
Bookmark
Share
View Full Paper